The Trend Catcher | SMTK (+36%) Leads Electronic-Semiconductor Equip; LLY (+3%) Hits ATH on New Weight-Loss Drug; Optical Stocks Surge: MRVL (+13%), GLW (+7%)

SmartKem
Nova
KLA
Applied Materials
Eli Lilly

SmartKem

SMTK

0.00

Nova

NVMI

0.00

KLA

KLAC

0.00

Applied Materials

AMAT

0.00

Eli Lilly

LLY

0.00

Subscribe to "The Trend Catcher Topic," tracking hottest sectors & technical breakouts in real time daily, accompanying you every US stock trading day.


1. Leader industry as of 5:34 pm

NamePrice % ChgInd Grp % Chg 3 MoNumber of StocksInd Group RSInd Group RankInd Grp Rnk 3 Mo Ago% Chg YTDInd Mkt Val (bil)
Elec-Semiconductor Equip4.99%39.0%33A+102367.5%2,151.4
Comml Svcs-Staffing4.76%45.6%25A1813417.5%131.4
Computer-Hardware/Perip4.68%139.2%36A+219199.7%1,972.3
Elec-Misc Products4.05%34.3%29A133657.5%263.5
Finance - Crypto/Blockchain3.39%15.9%76C-1021399.9%213.6

Elec-Semiconductor Equip: SmartKem, Inc.(SMTK.US), Nova Ltd.(NVMI.US), KLA(KLAC.US), Applied Materials, Inc.(AMAT.US) 

Market Today: Under the AI Theme, Beware of "Crowding" and "Divergence"

One-Sentence Summary: The U.S. equity trend remains intact, but the "margin for error" has narrowed significantly. AI remains the core theme, but the trading logic has shifted from "buying the story" to "buying the bottleneck," while crowding and interest rate risks are brewing short-term volatility.

Key Points

AI Hardware: From "Cyclical Boom" to "Chipflation," Focus on Three Bottlenecks

  • Memory Chips: HBM/DRAM supply remains tight, becoming the new "bottleneck" for AI compute. All three major players have passed HBM4 certification, and the price hike cycle is clear.
  • Optical Interconnects: CPO/1.6T is a defined path to solving network bottlenecks. Companies like Lumentum are seeing surging gross margins, with a supply-demand gap exceeding 30%.
  • Equipment/Power: Slow grid connections and exploding demand for liquid cooling are driving the push for 800V power supplies. Wafer Fab Equipment (WFE) spending forecasts are being raised. AI factories are shifting to "demand capacity from power and racks."

Sector Performance: A 30-70 Split – Who's Leading and Who's Lagging?

  • Strong (The 30%): Memory, Optical Interconnects, AI ASICs ($Broadcom), Cybersecurity (CIBR), Cloud Computing (SKYY). These sectors hold "key positions" with pricing power and order visibility.
  • Weak (The 70%): Large-cap platforms (e.g., Google, Amazon) are underperforming. Traditional consumer/platform sectors are under pressure from interest rates and valuation, failing to take over as market leaders.

Risk Warnings: Three Shadows Behind the AI Spotlight

  • Crowded Trade Reversal: The tech sector's weight in the S&P 500 has hit 39.7%, surpassing the peak of the 2000 dot-com bubble. The SOX index fell over 10% in one of its worst single-day performances ever. The risk of a violent deleveraging event persists.
  • Macro & Interest Rates: The May nonfarm payrolls surged by 172k. The market is now pricing in a rate hike by year-end. The discount rate pressure on high-valuation tech stocks from higher rates is no small threat.
  • Cracks in the AI Thesis: The debt-financed model for AI capex faces headwinds from a cooling credit market. Free cash flow for some hyperscalers is turning negative, raising execution risks for projects.

Trading Strategy: The market is in a "separating the wheat from the chaff" phase. Prioritize leaders in memory, optical interconnects, and equipment that enjoy pricing power and are protected by supply constraints. Be wary of high-beta AI plays that lack fundamental earnings delivery. The key metrics to watch next are hyperscaler capex signals, memory contract prices, and optical module orders to validate the "bottleneck trade" thesis.


2. Breaking Out Today as of 5:34 pm

SymbolComp RatingIndustry NameCurrent PricePrice % ChgVolume (1000s)EPS RatingRS RatingInd Group RSSMR RatingA/D RatingMarket Cap (mil)
Eli Lilly and Company(LLY.US) 99Medical - Pharmaceuti...1,162.922.781,3379979BAA-1,065,505.1

Eli Lilly and Company(LLY.US) announced that its experimental weight loss therapy, Foundayo, significantly aids overweight or obese women in losing weight, regardless of menopausal status. The findings, presented at the ADA annual meeting, analyzed data from over 1,500 participants in the ATTAIN-1 and ATTAIN-2 trials. Menopause often leads to metabolic changes, making weight loss challenging. Following the news, $LLY shares surged over 4%, reaching a record high.


3. Near Breakouts as of 5:54 pm

SymbolNameComp RatingIndustry NameCurrent PricePrice % ChgVolume (1000s)Price $ ChgEPSRS RatingInd Group RSSMR RatingA/D RatingMarket Cap (mil)
Marvell Technology(MRVL.US) Marvell Technology Inc.99Elec-Semiconductor Fab...300.9314.2234,44937.469499AAA230,483.6
Astera Labs(ALAB.US) Astera Labs Inc.98Elec-Semiconductor Fab...349.9110.361,59132.857098AAA54,346.6
Corning Inc(GLW.US) Corning Inc.94Elec-Misc Products191.637.915,11114.059095AEE152,832.1
STMicroelectronics NV Sponsored ADR RegS(STM.US) STMicroelectronics N.V.87Elec-Semiconductor Mfg76.177.705,2485.453698ADA64,784.9
Oceaneering International, Inc.(OII.US) Oceaneering International Inc.95Oil&Gas-Field Services39.115.28921.968684A-AC3,705.5
XPO, Inc.(XPO.US) XPO Inc.90Transportation-Logistics225.883.171686.948082BCC25,705.7

Subscribe to The Trend Catcher Topic / The Value Anchor Topic —unlock the full historical archive and never miss a weekly pick again.

Related Stocks Chart

Marvell Technology(MRVL.US) 

Company Fundamentals
EPS Due Date8/20/2026
EPS % Chg (Last Qtr)29%
3 Year EPS Growth Rate24%
EPS Est % Chg (Current Yr)38%
Annual ROE16%
Sales % Chg (Last Qtr)28%
3-Year Sales Growth Rate17%
Debt %31%
Market Cap$230 Bil
Annual Pre-Tax Margin3.45%
SectorChips
Industry GroupElec-Semiconductor Fabless
Industry Group Rank26

More of Our Investment Philosophy>>


Disclaimer: The content is provided as general information only and should not be taken as investment advice. All the contents shall not be taken as a recommendation to buy or sell any security or financial instruments. Any action you take resulting from information, analysis, or commentary on this article is your responsibility. Please consult your investment advisor before making any investments.